Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed clinical stage I-III gastric cancer 2) At least one of the following symptoms: decreased strength after illness, fatigue/malaise, anorexia, night sweats, cold limbs or anemia 3) Age of 20 years or older 4) Eastern Cooperative Oncology Group performance status of 0-2 5) Sufficient oral intake 6) Written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients scheduled to preoperative chemotherapy and/or radiotherapy 2) Any Japanese herbal medicine within 4 weeks before the commencement of the study 3) Allergy to Japanese herbal medicine 4) Severe comorbidities, such as liver disease, renal disease, heart disease, lung disease, hematologic disease and metabolic disease 5) Electrolyte abnormalities 6) Cardiac pacemaker 7) Severe mental disorder 8) Pregnancy 9) Patient who is judged to be unsuitable for inclusion in the study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of the ratio of skeletal muscle mass to body weight | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Change of body composition (2) Change of nutritional parameters (3) Adverse events and postoperative complications | — |
Countries
Japan
Contacts
Nara Medical University Surgery